Literature DB >> 25144627

A metabolic view on menopause and ageing.

Kirsi Auro1, Anni Joensuu2, Krista Fischer3, Johannes Kettunen4, Perttu Salo5, Hannele Mattsson5, Marjo Niironen6, Jaakko Kaprio7, Johan G Eriksson8, Terho Lehtimäki9, Olli Raitakari10, Antti Jula11, Aila Tiitinen12, Matti Jauhiainen5, Pasi Soininen13, Antti J Kangas13, Mika Kähönen14, Aki S Havulinna11, Mika Ala-Korpela15, Veikko Salomaa11, Andres Metspalu3, Markus Perola16.   

Abstract

The ageing of the global population calls for a better understanding of age-related metabolic consequences. Here we report the effects of age, sex and menopause on serum metabolites in 26,065 individuals of Northern European ancestry. Age-specific metabolic fingerprints differ significantly by gender and, in females, a substantial atherogenic shift overlapping the time of menopausal transition is observed. In meta-analysis of 10,083 women, menopause status associates with amino acids glutamine, tyrosine and isoleucine, along with serum cholesterol measures and atherogenic lipoproteins. Among 3,204 women aged 40-55 years, menopause status associates additionally with glycine and total, monounsaturated, and omega-7 and -9 fatty acids. Our findings suggest that, in addition to lipid alterations, menopause may contribute to future metabolic and cardiovascular risk via influencing amino-acid concentrations, adding to the growing evidence of the importance of amino acids in metabolic disease progression. These observations shed light on the metabolic consequences of ageing, gender and menopause at the population level.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25144627     DOI: 10.1038/ncomms5708

Source DB:  PubMed          Journal:  Nat Commun        ISSN: 2041-1723            Impact factor:   14.919


  72 in total

Review 1.  Metabolomics Signatures of Aging: Recent Advances.

Authors:  Sunil S Adav; Yulan Wang
Journal:  Aging Dis       Date:  2021-04-01       Impact factor: 6.745

2.  Comparing metabolite profiles of habitual diet in serum and urine.

Authors:  Mary C Playdon; Joshua N Sampson; Amanda J Cross; Rashmi Sinha; Kristin A Guertin; Kristin A Moy; Nathaniel Rothman; Melinda L Irwin; Susan T Mayne; Rachael Stolzenberg-Solomon; Steven C Moore
Journal:  Am J Clin Nutr       Date:  2016-08-10       Impact factor: 7.045

3.  Increased susceptibility to OVX-associated metabolic dysfunction in UCP1-null mice.

Authors:  Stephanie L Clookey; Rebecca J Welly; Terese M Zidon; MIchelle L Gastecki; Makenzie L Woodford; Zachary I Grunewald; Nathan C Winn; Dusti Eaton; Natalia G Karasseva; Harrold S Sacks; Jaume Padilla; Victoria Vieira-Potter
Journal:  J Endocrinol       Date:  2018-08-08       Impact factor: 4.286

4.  Metabolic Predictors of Incident Coronary Heart Disease in Women.

Authors:  Nina P Paynter; Raji Balasubramanian; Franco Giulianini; Dong D Wang; Lesley F Tinker; Shuba Gopal; Amy A Deik; Kevin Bullock; Kerry A Pierce; Justin Scott; Miguel A Martínez-González; Ramon Estruch; JoAnn E Manson; Nancy R Cook; Christine M Albert; Clary B Clish; Kathryn M Rexrode
Journal:  Circulation       Date:  2018-02-20       Impact factor: 29.690

5.  Inverse relationship between serum osteocalcin levels and nonalcoholic fatty liver disease in postmenopausal Chinese women with normal blood glucose levels.

Authors:  Yu-qi Luo; Xiao-jing Ma; Ya-ping Hao; Xiao-ping Pan; Yi-ting Xu; Qin Xiong; Yu-qian Bao; Wei-ping Jia
Journal:  Acta Pharmacol Sin       Date:  2015-11-16       Impact factor: 6.150

6.  Branched-chain amino acids, history of gestational diabetes, and breastfeeding: The Bogalusa Heart Study.

Authors:  Emily W Harville; Lydia Bazzano; Lu Qi; Jiang He; Kirsten Dorans; Wei Perng; Tanika Kelly
Journal:  Nutr Metab Cardiovasc Dis       Date:  2020-06-29       Impact factor: 4.222

7.  Efficacy of proline in the treatment of menopause.

Authors:  Sun-Young Nam; Myoung-Schook Yoou; Hyung-Min Kim; Hyun-Ja Jeong
Journal:  Exp Biol Med (Maywood)       Date:  2016-01-31

8.  Metabolomic profiles associated with all-cause mortality in the Women's Health Initiative.

Authors:  Raji Balasubramanian; Nina P Paynter; Franco Giulianini; JoAnn E Manson; Yibai Zhao; Jiu-Chiuan Chen; Mara Z Vitolins; Christine A Albert; Clary Clish; Kathryn M Rexrode
Journal:  Int J Epidemiol       Date:  2020-02-01       Impact factor: 7.196

9.  Reduced Apolipoprotein M and Adverse Outcomes Across the Spectrum of Human Heart Failure.

Authors:  Julio A Chirinos; Lei Zhao; Yi Jia; Cecilia Frej; Luigi Adamo; Douglas Mann; Swapnil V Shewale; John S Millar; Daniel J Rader; Benjamin French; Jeff Brandimarto; Kenneth B Margulies; John S Parks; Zhaoqing Wang; Dietmar A Seiffert; James Fang; Nancy Sweitzer; Christina Chistoffersen; Björn Dahlbäck; Bruce D Car; David A Gordon; Thomas P Cappola; Ali Javaheri
Journal:  Circulation       Date:  2020-04-02       Impact factor: 29.690

10.  Metabolite profiling and cardiovascular event risk: a prospective study of 3 population-based cohorts.

Authors:  Peter Würtz; Aki S Havulinna; Pasi Soininen; Tuulia Tynkkynen; David Prieto-Merino; Therese Tillin; Anahita Ghorbani; Anna Artati; Qin Wang; Mika Tiainen; Antti J Kangas; Johannes Kettunen; Jari Kaikkonen; Vera Mikkilä; Antti Jula; Mika Kähönen; Terho Lehtimäki; Debbie A Lawlor; Tom R Gaunt; Alun D Hughes; Naveed Sattar; Thomas Illig; Jerzy Adamski; Thomas J Wang; Markus Perola; Samuli Ripatti; Ramachandran S Vasan; Olli T Raitakari; Robert E Gerszten; Juan-Pablo Casas; Nish Chaturvedi; Mika Ala-Korpela; Veikko Salomaa
Journal:  Circulation       Date:  2015-01-08       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.